Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kristina Garuoliene"'
Autor:
Tamás Ágh, Maja Ortner Hadžiabdić, Kristina Garuoliene, Anne Gerd Granas, Emma Aarnio, Enrica Menditto, João Gregório, Pilar Barnestein-Fonseca, Vildan Mevsim, Przemysław Kardas, European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE)
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Current literature lacks detailed understanding of the reimbursement framework of medication adherence enhancing interventions (MAEIs). As part of the ENABLE COST Action, the EUREcA (“EUropen REimbursement strategies for interventions
Externí odkaz:
https://doaj.org/article/46290b8d358649518348117fb7c9097c
Autor:
Brian Godman, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Carlos Vassalo, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M. Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Godfrey Mutashambara Rwegerera, Renata Cristina Rezende Macedo do Nascimento, Isabella Piassi Dias Godói, Mohammed Irfan, Adefolarin A. Amu, Patrick Matowa, Joseph Acolatse, Robert Incoom, Israel Abebrese Sefah, Jitendra Acharya, Sylvia Opanga, Lisper Wangeci Njeri, David Kimonge, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Oliver Ombeva Malande, Thereza Piloya-Were, Rosana Gambogi, Carla Hernandez Ortiz, Luke Alutuli, Aubrey Chichonyi Kalungia, Iris Hoxha, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Ott Laius, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuoliene, Jolanta Gulbinovič, Magdalene Wladysiuk, Jakub Rutkowski, Ileana Mardare, Jurij Fürst, Stuart McTaggart, Sean MacBride-Stewart, Caridad Pontes, Corinne Zara, Eunice Twumwaa Tagoe, Rita Banzi, Janney Wale, Mihajlo Jakovljevic
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control inclu
Externí odkaz:
https://doaj.org/article/21e165a45cc44a40aaaa93c7005bfdad
Autor:
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc Van De Casteele, Eduardo Diogene, Jurij Furst, Kristina Garuoliene, Martin van der Graaff, Jolanta Gulbinovic, Alan Haycox, Jan Jones, Roberta Joppi, Ott Laius, Irene Langner, Anthony Martin, Vanda Markovic-Pekovic, Laura McCullagh, Einar Magnusson, Ellen Nilsen, Gisbert Selke, Catherine Sermet, Steven Simoens, Robert Sauermann, Ad Schuurman, Ricardo Ramos, Vera Vlahovic-Palcevski, Corinne Zara, Brian Godman
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Payers are a major stakeholder in any considerations and initiatives concerning adaptive licensing of new medicinal products, also referred to as Medicines Adaptive Pathways to patients (MAPPs). Firstly, the scope and necessity of MAPPs need further
Externí odkaz:
https://doaj.org/article/40d4ad711a0845b293f34d8201689534
Autor:
Brian Godman, Marion Bennie, Christoph Baumgärtel, Ljiljana Sović-Brkičić, Thomas Burkhardt, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Vanda Markovic-Pekovic, Andrew Martin, Catherine Sermet, Peter Skiold, Menno van Woerkom, Luka Voncina, Lars L. Gustafsson
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 13, Iss 3S, Pp 5-20 (2012)
INTRODUCTION: Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a cl
Externí odkaz:
https://doaj.org/article/df7632e532124a708875c84591b2c311
Introduction: Current literature lacks detailed understanding of the reimbursement framework of medication adherence enhancing interventions (MAEIs). As part of the ENABLE COST Action, the EUREcA (“EUropen REimbursement strategies for interventions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::54748eb9ceadd3e7c8bab40cbc027557
https://www.bib.irb.hr/1253475
https://www.bib.irb.hr/1253475
Autor:
Brian Godman, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Carlos Vassalo, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M. Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Godfrey Mutashambara Rwegerera, Renata Cristina Rezende Macedo do Nascimento, Isabella Piassi Dias Godói, Mohammed Irfan, Adefolarin A. Amu, Patrick Matowa, Joseph Acolatse, Robert Incoom, Israel Abebrese Sefah, Jitendra Acharya, Sylvia Opanga, Lisper Wangeci Njeri, David Kimonge, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Oliver Ombeva Malande, Thereza Piloya-Were, Rosana Gambogi, Carla Hernandez Ortiz, Luke Alutuli, Aubrey Chichonyi Kalungia, Iris Hoxha, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Ott Laius, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuoliene, Jolanta Gulbinovič, Magdalene Wladysiuk, Jakub Rutkowski, Ileana Mardare, Jurij Fürst, Stuart McTaggart, Sean MacBride-Stewart, Caridad Pontes, Corinne Zara, Eunice Twumwaa Tagoe, Rita Banzi, Janney Wale, Mihajlo Jakovljevic
Publikováno v:
Frontiers in Public Health
Frontiers in Public Health, Vol 9 (2021)
Frontiers in public health, Lausanne : Frontiers media SA, 2021, vol. 9, art. no. 671961, p. [1-21]
Frontiers in Public Health, Vol 9 (2021)
Frontiers in public health, Lausanne : Frontiers media SA, 2021, vol. 9, art. no. 671961, p. [1-21]
Background:Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8bfd907fdb35ac21322774ecebaac5
https://strathprints.strath.ac.uk/76306/7/Godman_etal_FPH_2021_The_current_situation_regarding_long_acting_insulin_analogues_including.pdf
https://strathprints.strath.ac.uk/76306/7/Godman_etal_FPH_2021_The_current_situation_regarding_long_acting_insulin_analogues_including.pdf
Autor:
Corinne Zara Yahni, Koji Kawakami, Yu-Chiau Shyu, Svetlana Skurtveit, Takuya Kinoshita, Lise Aagaard, Jorge Enrique Machado-Alba, Izumi Sato, Helga Zoega, Sallie-Anne Pearson, Kari Furu, Catharina C. M. Schuiling-Veninga, Christian Bachmann, Falk Hoffmann, Johan Reutfors, Melisa Litchfield, Miquel Bernardo, Soffy C. López, Manuel Enrique Machado-Duque, Luuk J. Kalverdijk, Helle Kieler, Anna Coma Fusté, Prasad S. Nishtala, Lena Brandt, Mufaddal Mahesri, Krista F. Huybrechts, Liang-Jen Wang, Kristina Garuoliene, Hélène Verdoux, Oskar Halfdanarson, Leena K. Saastamoinen
Publikováno v:
European Neuropsychopharmacology, 27(10), 1064-1076. ELSEVIER SCIENCE BV
The objective of this study was to assess international trends in antipsychotic use, using a standardised methodology. A repeated cross-sectional design was applied to data extracts from the years 2005 to 2014 from 16 countries worldwide. During the
Autor:
Tomasz Bochenek, Marianne Van-De-Lisle, Christoffel Grobler, James Mwanza, Amos Massele, Ruaraidh Hill, Tanveer A. Khan, Dan Kibuule, Janney Wale, Kayode Dominion Samuel Bamitale, Corrado Barbui, Konstantin Tachkov, Wallace Breno Barbosa, Alian A. Alrasheedy, Joseph O Fadare, Kristina Garuoliene, Suhaj Abdulsalim, Shahzad Hussain, Francis Kalemeera, Israel Abebrese Sefah, Brian Godman, Guenka Petrova, Antony P. Martin, Aubrey Chichonyi Kalungia, Mazhuvancherry Kesavan Unnikrishnan, Philip Opondo
Publikováno v:
Expert Opinion on Pharmacotherapy
EXPERT OPINION ON PHARMACOTHERAPY
EXPERT OPINION ON PHARMACOTHERAPY
Introduction: Appropriately managing mental disorders is a growing priority across countries in view of the impact on morbidity and mortality. This includes patients with bipolar disorders (BD). Management of BD is a concern as this is a complex dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71bedce2649b1087a8a238a821c6adc
https://ruj.uj.edu.pl/xmlui/handle/item/256560
https://ruj.uj.edu.pl/xmlui/handle/item/256560
Autor:
Stuart McTaggart, Kristina Garuoliene, Jurij Fürst, Scott M Bryson, Andrew Martin, Winne de Bruyn, Antra Fogele, Agnes Vitry, Hanne Bak Pedersen, Catherine Sermet, Gisbert Selke, Anne Marthe Ringerud, Krijn Schiffers, Eva Andersén Karlsson, Michael Wilcock, Anita Viksna, Irene Langner, Ljiljana Sović-Brkičić, Anna Coma Fusté, Marija Kalaba, Mikael Hoffmann, Peter Skiold, Sisira Jayathissa, Vanda Marković-Peković, Tomasz Bochenek, Einar Magnusson, Ott Laius, Christoph Baumgärtel, Scott Metcalfe, Corinne Zara, Brian Godman, D Tomek, Jutta Piessnegger, Rickard E. Malmström, Juraj Slabý, Harald Herholz, Jessica Fraeyman, Hye-Young Kwon, Marco D’Agata
Publikováno v:
Generics and Biosimilars Initiative Journal. 4:125-135
The manufacturer of pregabalin has a second use patent covering prescribing for neuropathic pain: its principal indication. The manufacturer has threatened legal action in the UK if generic pregabalin rather than Lyrica is prescribed for this indicat
Autor:
Edmundas Kaduševičius, Egle Karinauske, Vilma Morkuniene, Kristina Garuoliene, Skaiste Kasciuskeviciute
Publikováno v:
Medicine
The purpose of this study was to determine the trends in consumption of antibiotics and evaluate the antibiotic prescription rates in the pediatric population in Lithuania during 2003 to 2012. A cross-sectional study. Data of systemic antibiotic use